← All trials
NCT03363997
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 23, 2016
- Primary completion
- Dec 15, 2016
- Completion date
- Jun 6, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 31
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Galeno Desenvolvimento de PesquisasLead sponsor
- Galeno Desenvolvimento de PesquisasReponsible party - principal investigator
- Galeno Desenvolvimento de PesquisasOverall official - principal investigator
- SocraTec R&D GmbHCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.